Radioactive iodine-125 seeds in the localisation of breast tumours
Iodine-125 seeds have been licensed for use in prostate cancer for many years. Since 2001 there has been growing evidence for radioactive seed localisation (RSL) off-licence to mark breast tumours prior to wide local excision (WLE). The seeds are about the size of a grain of rice. The titanium shell houses a ceramic core impregnated […]
Richard Peace, George Petrides, Carol Ellen Holmes, Nidhi Sibal
The Newcastle upon Tyne Hospitals NHS Foundation Trust